Indygokarmin Serb (Indigo Carmine)

Indigo Carmine is employed as a diagnostic dye in procedures that require visual enhancement of bodily fluids or tissues.

• Urological procedures: highlights the urinary tract to improve visualization during cystoscopy or catheterization.
• Cardiac catheterization: delineates cardiac chambers and coronary vessels for clearer angiographic assessment.
• Laparoscopic surgery: stains the peritoneal cavity, aiding identification of anatomical structures and potential leaks.

• Indigo Carmine is a water‑soluble anionic dye that, after intravenous injection, binds to plasma proteins and circulates through the vascular system. It is excreted unchanged by the kidneys, imparting a vivid blue color to urine and extracellular fluids, thereby allowing clinicians to visually assess the flow and integrity of anatomical pathways during diagnostic and operative procedures.

Adverse reactions to Indigo Carmine may vary in frequency and severity.

Common Side Effects

• Transient hypotension: brief drop in blood pressure following injection.
• Mild nausea: occasional stomach discomfort.
• Headache: short‑lasting head pain.

Serious or Rare Side Effects

• Anaphylactic reaction: severe allergic response requiring immediate medical intervention.
• Severe hypertension: abrupt increase in blood pressure.
• Methemoglobinemia: rare alteration of hemoglobin affecting oxygen transport.

When using Indigo Carmine, clinicians should observe several safety measures.

• Allergy assessment: screen patients for known hypersensitivity to synthetic dyes.
• Renal function: monitor individuals with impaired kidney function due to renal excretion.
• Cardiovascular status: observe for blood pressure fluctuations during and after administration.
• Pregnancy and lactation: use only if the anticipated diagnostic benefit outweighs potential risk.
• Store at ambient temperature: keep in the original container, protect from light and moisture.

Indigo Carmine may interact with other medications; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid)

• Iodinated contrast media: concurrent use may increase the risk of renal toxicity.
• Other intravenous dyes: combined administration can lead to additive toxicity.
• Beta‑blockers: may mask hypotensive responses to the dye.

Moderate Interactions (Monitor Closely)

• Diuretics: may enhance urinary discoloration, affecting visual assessment.
• ACE inhibitors: monitor blood pressure for additive effects.
• Antihistamines: may reduce the intensity of allergic reactions, potentially masking early signs.